Skip to main content
Erschienen in: Angiogenesis 4/2014

01.10.2014 | Original Paper

Mechanisms of vasculogenesis in 3D fibrin matrices mediated by the interaction of adipose-derived stem cells and endothelial cells

verfasst von: Sabrina Rohringer, Pablo Hofbauer, Karl H. Schneider, Anna-Maria Husa, Georg Feichtinger, Anja Peterbauer-Scherb, Heinz Redl, Wolfgang Holnthoner

Erschienen in: Angiogenesis | Ausgabe 4/2014

Einloggen, um Zugang zu erhalten

Abstract

Vascularization of tissue-engineered constructs is essential to provide sufficient nutrient supply and hemostasis after implantation into target sites. Co-cultures of adipose-derived stem cells (ASC) with outgrowth endothelial cells (OEC) in fibrin gels were shown to provide an effective possibility to induce vasculogenesis in vitro. However, the mechanisms of the interaction between these two cell types remain unclear so far. The aim of this study was to evaluate differences of direct and indirect stimulation of ASC-induced vasculogenesis, the influence of ASC on network stabilization and molecular mechanisms involved in vascular structure formation. Endothelial cells (EC) were embedded in fibrin gels either containing non-coated or ASC-coated microcarrier beads as well as ASC alone. Moreover, EC-seeded constructs incubated with ASC-conditioned medium were used in addition to constructs with ASC seeded on top. Vascular network formation was visualized by green fluorescent protein expressing cells or immunostaining for CD31 and quantified. RT-qPCR of cells derived from co-cultures in fibrin was performed to evaluate changes in the expression of EC marker genes during the first week of culture. Moreover, angiogenesis-related protein levels were measured by performing angiogenesis proteome profiler arrays. The results demonstrate that proximity of endothelial cells and ASC is required for network formation and ASC stabilize EC networks by developing pericyte characteristics. We further showed that ASC induce controlled vessel growth by secreting pro-angiogenic and regulatory proteins. This study reveals angiogenic protein profiles involved in EC/ASC interactions in fibrin matrices and confirms the usability of OEC/ASC co-cultures for autologous vascular tissue engineering.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Mikos AG, Sarakinos G, Lyman MD, Ingber DE, Vacanti JP, Langer R (1993) Prevascularization of porous biodegradable polymers. Biotechnol Bioeng 42:716–723PubMedCrossRef Mikos AG, Sarakinos G, Lyman MD, Ingber DE, Vacanti JP, Langer R (1993) Prevascularization of porous biodegradable polymers. Biotechnol Bioeng 42:716–723PubMedCrossRef
2.
Zurück zum Zitat Richardson TP, Peters MC, Ennett AB, Mooney DJ (2001) Polymeric system for dual growth factor delivery. Nat Biotechnol 19:1029–1034PubMedCrossRef Richardson TP, Peters MC, Ennett AB, Mooney DJ (2001) Polymeric system for dual growth factor delivery. Nat Biotechnol 19:1029–1034PubMedCrossRef
3.
Zurück zum Zitat Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J (2000) Vascular-specific growth factors and blood vessel formation. Nature 407:242–248PubMedCrossRef Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J (2000) Vascular-specific growth factors and blood vessel formation. Nature 407:242–248PubMedCrossRef
4.
Zurück zum Zitat Edelman ER, Mathiowitz E, Langer R, Klagsbrun M (1991) Controlled and modulated release of basic fibroblast growth factor. Biomaterials 12:619–626PubMedCrossRef Edelman ER, Mathiowitz E, Langer R, Klagsbrun M (1991) Controlled and modulated release of basic fibroblast growth factor. Biomaterials 12:619–626PubMedCrossRef
5.
Zurück zum Zitat Murphy WL, Peters MC, Kohn DH, Mooney DJ (2000) Sustained release of vascular endothelial growth factor from mineralized poly(lactide-co-glycolide) scaffolds for tissue engineering. Biomaterials 21:2521–2527PubMedCrossRef Murphy WL, Peters MC, Kohn DH, Mooney DJ (2000) Sustained release of vascular endothelial growth factor from mineralized poly(lactide-co-glycolide) scaffolds for tissue engineering. Biomaterials 21:2521–2527PubMedCrossRef
6.
Zurück zum Zitat Soker S, Machado M, Atala A (2000) Systems for therapeutic angiogenesis in tissue engineering. World J Urol 18:10–18PubMedCrossRef Soker S, Machado M, Atala A (2000) Systems for therapeutic angiogenesis in tissue engineering. World J Urol 18:10–18PubMedCrossRef
7.
Zurück zum Zitat Nomi M, Atala A, Coppi PD, Soker S (2002) Principals of neovascularization for tissue engineering. Mol Asp Med 23:463–483CrossRef Nomi M, Atala A, Coppi PD, Soker S (2002) Principals of neovascularization for tissue engineering. Mol Asp Med 23:463–483CrossRef
8.
Zurück zum Zitat Fuchs S, Hofmann A, Kirkpatrick CJ (2007) Microvessel-like structures from outgrowth endothelial cells from human peripheral blood in 2-dimensional and 3-dimensional co-cultures with osteoblastic lineage cells. Tissue Eng 13:2577–2588PubMedCrossRef Fuchs S, Hofmann A, Kirkpatrick CJ (2007) Microvessel-like structures from outgrowth endothelial cells from human peripheral blood in 2-dimensional and 3-dimensional co-cultures with osteoblastic lineage cells. Tissue Eng 13:2577–2588PubMedCrossRef
9.
Zurück zum Zitat Berthod F, Germain L, Tremblay N, Auger FA (2006) Extracellular matrix deposition by fibroblasts is necessary to promote capillary-like tube formation in vitro. J Cell Physiol 207:491–498PubMedCrossRef Berthod F, Germain L, Tremblay N, Auger FA (2006) Extracellular matrix deposition by fibroblasts is necessary to promote capillary-like tube formation in vitro. J Cell Physiol 207:491–498PubMedCrossRef
10.
Zurück zum Zitat Nakatsu MN, Sainson RCA, Aoto JN, Taylor KL, Aitkenhead M, Pérez-del-Pulgar S, Carpenter PM, Hughes CCW (2003) Angiogenic sprouting and capillary lumen formation modeled by human umbilical vein endothelial cells (HUVEC) in fibrin gels: the role of fibroblasts and Angiopoietin-1. Microvasc Res 66:102–112PubMedCrossRef Nakatsu MN, Sainson RCA, Aoto JN, Taylor KL, Aitkenhead M, Pérez-del-Pulgar S, Carpenter PM, Hughes CCW (2003) Angiogenic sprouting and capillary lumen formation modeled by human umbilical vein endothelial cells (HUVEC) in fibrin gels: the role of fibroblasts and Angiopoietin-1. Microvasc Res 66:102–112PubMedCrossRef
11.
Zurück zum Zitat Elbjeirami WM, West JL (2006) Angiogenesis-like activity of endothelial cells co-cultured with VEGF-producing smooth muscle cells. Tissue Eng 12:381–390PubMedCrossRef Elbjeirami WM, West JL (2006) Angiogenesis-like activity of endothelial cells co-cultured with VEGF-producing smooth muscle cells. Tissue Eng 12:381–390PubMedCrossRef
12.
Zurück zum Zitat Ucuzian AA, Bufalino DV, Pang Y, Greisler HP (2013) Angiogenic endothelial cell invasion into fibrin is stimulated by proliferating smooth muscle cells. Microvasc Res 90:40–47PubMedCrossRef Ucuzian AA, Bufalino DV, Pang Y, Greisler HP (2013) Angiogenic endothelial cell invasion into fibrin is stimulated by proliferating smooth muscle cells. Microvasc Res 90:40–47PubMedCrossRef
13.
Zurück zum Zitat Strassburg S, Nienhueser H, Stark GB, Finkenzeller G, Torio-Padron N (2013) Human adipose-derived stem cells enhance the angiogenic potential of endothelial progenitor cells, but not of human umbilical vein endothelial cells. Tissue Eng Part A 19:166–174PubMedCrossRef Strassburg S, Nienhueser H, Stark GB, Finkenzeller G, Torio-Padron N (2013) Human adipose-derived stem cells enhance the angiogenic potential of endothelial progenitor cells, but not of human umbilical vein endothelial cells. Tissue Eng Part A 19:166–174PubMedCrossRef
14.
Zurück zum Zitat Moioli EK, Clark PA, Chen M, Dennis JE, Erickson HP, Gerson SL, Mao JJ (2008) Synergistic actions of hematopoietic and mesenchymal stem/progenitor cells in vascularizing bioengineered tissues. PLoS One 3:e3922PubMedCrossRefPubMedCentral Moioli EK, Clark PA, Chen M, Dennis JE, Erickson HP, Gerson SL, Mao JJ (2008) Synergistic actions of hematopoietic and mesenchymal stem/progenitor cells in vascularizing bioengineered tissues. PLoS One 3:e3922PubMedCrossRefPubMedCentral
15.
Zurück zum Zitat Park IS, Kim SH, Jung Y, Rhie JW, Kim SH (2013) Endothelial differentiation and vasculogenesis induced by three-dimensional adipose-derived stem cells. Anat Rec Adv Integr Anat Evol Biol 296:168–177CrossRef Park IS, Kim SH, Jung Y, Rhie JW, Kim SH (2013) Endothelial differentiation and vasculogenesis induced by three-dimensional adipose-derived stem cells. Anat Rec Adv Integr Anat Evol Biol 296:168–177CrossRef
16.
Zurück zum Zitat Ghajar CM, Blevins KS, Hughes CCW, George SC, Putnam AJ (2006) Mesenchymal stem cells enhance angiogenesis in mechanically viable prevascularized tissues via early matrix metalloproteinase upregulation. Tissue Eng 12:2875–2888PubMedCrossRef Ghajar CM, Blevins KS, Hughes CCW, George SC, Putnam AJ (2006) Mesenchymal stem cells enhance angiogenesis in mechanically viable prevascularized tissues via early matrix metalloproteinase upregulation. Tissue Eng 12:2875–2888PubMedCrossRef
18.
Zurück zum Zitat Holnthoner W, Hohenegger K, Husa AM, Muehleder S, Meinl A, Peterbauer-Scherb A, Redl H (2012) Adipose-derived stem cells induce vascular tube formation of outgrowth endothelial cells in a fibrin matrix. J Tissue Eng Regen Med. doi:10.1002/term PubMed Holnthoner W, Hohenegger K, Husa AM, Muehleder S, Meinl A, Peterbauer-Scherb A, Redl H (2012) Adipose-derived stem cells induce vascular tube formation of outgrowth endothelial cells in a fibrin matrix. J Tissue Eng Regen Med. doi:10.​1002/​term PubMed
19.
Zurück zum Zitat Fuchs S, Dohle E, Kolbe M, Kirkpatrick CJ (2010) Outgrowth endothelial cells: sources, characteristics and potential applications in tissue engineering and regenerative medicine. Bioreactor systems for tissue engineering II. Springer, Berlin Fuchs S, Dohle E, Kolbe M, Kirkpatrick CJ (2010) Outgrowth endothelial cells: sources, characteristics and potential applications in tissue engineering and regenerative medicine. Bioreactor systems for tissue engineering II. Springer, Berlin
20.
Zurück zum Zitat Kachgal S, Putnam AJ (2011) Mesenchymal stem cells from adipose and bone marrow promote angiogenesis via distinct cytokine and protease expression mechanisms. Angiogenesis 14:47–59PubMedCrossRefPubMedCentral Kachgal S, Putnam AJ (2011) Mesenchymal stem cells from adipose and bone marrow promote angiogenesis via distinct cytokine and protease expression mechanisms. Angiogenesis 14:47–59PubMedCrossRefPubMedCentral
21.
Zurück zum Zitat Verseijden F, Posthumus-van Sluijs SJ, van Neck JW, Hofer SOP, Hovius SER, van Osch GJVM (2012) Vascularization of prevascularized and non-prevascularized fibrin-based human adipose tissue constructs after implantation in nude mice. J Tissue Eng Regen Med 6:169–178PubMedCrossRef Verseijden F, Posthumus-van Sluijs SJ, van Neck JW, Hofer SOP, Hovius SER, van Osch GJVM (2012) Vascularization of prevascularized and non-prevascularized fibrin-based human adipose tissue constructs after implantation in nude mice. J Tissue Eng Regen Med 6:169–178PubMedCrossRef
22.
Zurück zum Zitat Rao RR, Peterson AW, Ceccarelli J, Putnam AJ, Stegemann JP (2012) Matrix composition regulates three-dimensional network formation by endothelial cells and mesenchymal stem cells in collagen/fibrin materials. Angiogenesis 15:253–264PubMedCrossRefPubMedCentral Rao RR, Peterson AW, Ceccarelli J, Putnam AJ, Stegemann JP (2012) Matrix composition regulates three-dimensional network formation by endothelial cells and mesenchymal stem cells in collagen/fibrin materials. Angiogenesis 15:253–264PubMedCrossRefPubMedCentral
23.
Zurück zum Zitat Buchta C, Hedrich HC, Macher M, Höcker P, Redl H (2005) Biochemical characterization of autologous fibrin sealants produced by CryoSeal® and Vivostat® in comparison to the homologous fibrin sealant product Tissucol/Tisseel®. Biomaterials 26:6233–6241PubMedCrossRef Buchta C, Hedrich HC, Macher M, Höcker P, Redl H (2005) Biochemical characterization of autologous fibrin sealants produced by CryoSeal® and Vivostat® in comparison to the homologous fibrin sealant product Tissucol/Tisseel®. Biomaterials 26:6233–6241PubMedCrossRef
24.
Zurück zum Zitat Fortelny RH, Petter-Puchner AH, Ferguson J, Gruber-Blum S, Brand J, Mika K, Redl H (2011) A comparative biomechanical evaluation of hernia mesh fixation by fibrin sealant. J Surg Res 171:576–581PubMedCrossRef Fortelny RH, Petter-Puchner AH, Ferguson J, Gruber-Blum S, Brand J, Mika K, Redl H (2011) A comparative biomechanical evaluation of hernia mesh fixation by fibrin sealant. J Surg Res 171:576–581PubMedCrossRef
25.
Zurück zum Zitat Peterbauer-Scherb A, Danzer M, Gabriel C, van Griensven M, Redl H, Wolbank S (2012) In vitro adipogenesis of adipose-derived stem cells in 3D fibrin matrix of low component concentration. J Tissue Eng Regen Med 6:434–442PubMedCrossRef Peterbauer-Scherb A, Danzer M, Gabriel C, van Griensven M, Redl H, Wolbank S (2012) In vitro adipogenesis of adipose-derived stem cells in 3D fibrin matrix of low component concentration. J Tissue Eng Regen Med 6:434–442PubMedCrossRef
26.
Zurück zum Zitat Wolbank S, Peterbauer A, Fahrner M, Hennerbichler S, van Griensven M, Stadler G, Redl H, Gabriel C (2007) Dose-dependent immunomodulatory effect of human stem cells from amniotic membrane: a comparison with human mesenchymal stem cells from adipose tissue. Tissue Eng 13:1173–1183PubMedCrossRef Wolbank S, Peterbauer A, Fahrner M, Hennerbichler S, van Griensven M, Stadler G, Redl H, Gabriel C (2007) Dose-dependent immunomodulatory effect of human stem cells from amniotic membrane: a comparison with human mesenchymal stem cells from adipose tissue. Tissue Eng 13:1173–1183PubMedCrossRef
27.
Zurück zum Zitat Petzelbauer P, Bender JR, Wilson J, Pober JS (1993) Heterogeneity of dermal microvascular endothelial cell antigen expression and cytokine responsiveness in situ and in cell culture. J Immunol 151:5062–5072PubMed Petzelbauer P, Bender JR, Wilson J, Pober JS (1993) Heterogeneity of dermal microvascular endothelial cell antigen expression and cytokine responsiveness in situ and in cell culture. J Immunol 151:5062–5072PubMed
28.
Zurück zum Zitat Bouïs D, Kusumanto Y, Meijer C, Mulder NH, Hospers GAP (2006) A review on pro- and anti-angiogenic factors as targets of clinical intervention. Pharmacol Res 53:89–103PubMedCrossRef Bouïs D, Kusumanto Y, Meijer C, Mulder NH, Hospers GAP (2006) A review on pro- and anti-angiogenic factors as targets of clinical intervention. Pharmacol Res 53:89–103PubMedCrossRef
29.
Zurück zum Zitat Carrion B, Kong YP, Kaigler D, Putnam AJ (2013) Bone marrow-derived mesenchymal stem cells enhance angiogenesis via their α6β1 integrin receptor. Exp Cell Res 319:2964–2976PubMedCrossRef Carrion B, Kong YP, Kaigler D, Putnam AJ (2013) Bone marrow-derived mesenchymal stem cells enhance angiogenesis via their α6β1 integrin receptor. Exp Cell Res 319:2964–2976PubMedCrossRef
30.
Zurück zum Zitat Hoch AI, Binder BY, Genetos DC, Leach JK (2012) Differentiation-dependent secretion of proangiogenic factors by mesenchymal stem cells. PLoS One 7:e35579PubMedCrossRefPubMedCentral Hoch AI, Binder BY, Genetos DC, Leach JK (2012) Differentiation-dependent secretion of proangiogenic factors by mesenchymal stem cells. PLoS One 7:e35579PubMedCrossRefPubMedCentral
31.
Zurück zum Zitat Gerhardt H, Betsholtz C (2003) Endothelial-pericyte interactions in angiogenesis. Cell Tissue Res 314:15–23PubMedCrossRef Gerhardt H, Betsholtz C (2003) Endothelial-pericyte interactions in angiogenesis. Cell Tissue Res 314:15–23PubMedCrossRef
32.
Zurück zum Zitat DeLisser HM, Christofidou-Solomidou M, Strieter RM, Burdick MD, Robinson CS, Wexler RS, Kerr JS, Garlanda C, Merwin JR, Madri JA, Albelda SM (1997) Involvement of endothelial PECAM-1/CD31 in angiogenesis. Am J Pathol 151:671–677PubMedPubMedCentral DeLisser HM, Christofidou-Solomidou M, Strieter RM, Burdick MD, Robinson CS, Wexler RS, Kerr JS, Garlanda C, Merwin JR, Madri JA, Albelda SM (1997) Involvement of endothelial PECAM-1/CD31 in angiogenesis. Am J Pathol 151:671–677PubMedPubMedCentral
33.
Zurück zum Zitat Bach TL, Barsigian C, Chalupowicz DG, Busler D, Yaen CH, Grant DS, Martinez J (1998) VE-cadherin mediates endothelial cell capillary tube formation in fibrin and collagen gels. Exp Cell Res 238:324–334PubMedCrossRef Bach TL, Barsigian C, Chalupowicz DG, Busler D, Yaen CH, Grant DS, Martinez J (1998) VE-cadherin mediates endothelial cell capillary tube formation in fibrin and collagen gels. Exp Cell Res 238:324–334PubMedCrossRef
34.
Zurück zum Zitat Mustonen T, Alitalo K (1995) Endothelial receptor tyrosine kinases involved in angiogenesis. J Cell Biol 129:895–898PubMedCrossRef Mustonen T, Alitalo K (1995) Endothelial receptor tyrosine kinases involved in angiogenesis. J Cell Biol 129:895–898PubMedCrossRef
35.
Zurück zum Zitat Starke RD, Ferraro F, Paschalaki KE, Dryden NH, McKinnon TAJ, Sutton RE, Payne EM, Haskard DO, Hughes AD, Cutler DF, Laffan MA, Randi AM (2011) Endothelial von Willebrand factor regulates angiogenesis. Blood 117:1071–1080PubMedCrossRefPubMedCentral Starke RD, Ferraro F, Paschalaki KE, Dryden NH, McKinnon TAJ, Sutton RE, Payne EM, Haskard DO, Hughes AD, Cutler DF, Laffan MA, Randi AM (2011) Endothelial von Willebrand factor regulates angiogenesis. Blood 117:1071–1080PubMedCrossRefPubMedCentral
36.
Zurück zum Zitat Cao R, Bråkenhielm E, Pawliuk R, Wariaro D, Post MJ, Wahlberg E, Leboulch P, Cao Y (2003) Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2. Nat Med 9:604–613PubMedCrossRef Cao R, Bråkenhielm E, Pawliuk R, Wariaro D, Post MJ, Wahlberg E, Leboulch P, Cao Y (2003) Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2. Nat Med 9:604–613PubMedCrossRef
37.
Zurück zum Zitat Nadar SK, Blann A, Beevers DG, Lip GYH (2005) Abnormal angiopoietins 1&2, angiopoietin receptor Tie-2 and vascular endothelial growth factor levels in hypertension: relationship to target organ damage [a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)]. J Intern Med 258:336–343PubMedCrossRef Nadar SK, Blann A, Beevers DG, Lip GYH (2005) Abnormal angiopoietins 1&2, angiopoietin receptor Tie-2 and vascular endothelial growth factor levels in hypertension: relationship to target organ damage [a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)]. J Intern Med 258:336–343PubMedCrossRef
38.
Zurück zum Zitat O’Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR, Folkman J (1997) Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88:277–285PubMedCrossRef O’Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR, Folkman J (1997) Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88:277–285PubMedCrossRef
39.
Zurück zum Zitat Gately S, Twardowski P, Stack MS, Cundiff DL, Grella D, Castellino FJ, Enghild J, Kwaan HC, Lee F, Kramer RA, Volpert O, Bouck N, Soff GA (1997) The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin. PNAS 94:10868–10872PubMedCrossRefPubMedCentral Gately S, Twardowski P, Stack MS, Cundiff DL, Grella D, Castellino FJ, Enghild J, Kwaan HC, Lee F, Kramer RA, Volpert O, Bouck N, Soff GA (1997) The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin. PNAS 94:10868–10872PubMedCrossRefPubMedCentral
40.
Zurück zum Zitat Stetler-Stevenson WG (1999) Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention. J Clin Investig 103:1237–1241PubMedCrossRefPubMedCentral Stetler-Stevenson WG (1999) Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention. J Clin Investig 103:1237–1241PubMedCrossRefPubMedCentral
41.
Zurück zum Zitat Li A, Dubey S, Varney ML, Dave BJ, Singh RK (2003) IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J Immunol 170:3369–3376PubMedCrossRef Li A, Dubey S, Varney ML, Dave BJ, Singh RK (2003) IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J Immunol 170:3369–3376PubMedCrossRef
42.
Zurück zum Zitat Li C, Hampson IN, Hampson L, Kumar P, Bernabeu C, Kumar S (2000) CD105 antagonizes the inhibitory signaling of transforming growth factor β1 on human vascular endothelial cells. FASEB J 14:55–64PubMed Li C, Hampson IN, Hampson L, Kumar P, Bernabeu C, Kumar S (2000) CD105 antagonizes the inhibitory signaling of transforming growth factor β1 on human vascular endothelial cells. FASEB J 14:55–64PubMed
43.
Zurück zum Zitat Rusnati M, Camozzi M, Moroni E, Bottazzi B, Peri G, Indraccolo S, Amadori A, Mantovani A, Presta M (2004) Selective recognition of fibroblast growth factor-2 by the long pentraxin PTX3 inhibits angiogenesis. Blood 104:92–99PubMedCrossRef Rusnati M, Camozzi M, Moroni E, Bottazzi B, Peri G, Indraccolo S, Amadori A, Mantovani A, Presta M (2004) Selective recognition of fibroblast growth factor-2 by the long pentraxin PTX3 inhibits angiogenesis. Blood 104:92–99PubMedCrossRef
Metadaten
Titel
Mechanisms of vasculogenesis in 3D fibrin matrices mediated by the interaction of adipose-derived stem cells and endothelial cells
verfasst von
Sabrina Rohringer
Pablo Hofbauer
Karl H. Schneider
Anna-Maria Husa
Georg Feichtinger
Anja Peterbauer-Scherb
Heinz Redl
Wolfgang Holnthoner
Publikationsdatum
01.10.2014
Verlag
Springer Netherlands
Erschienen in
Angiogenesis / Ausgabe 4/2014
Print ISSN: 0969-6970
Elektronische ISSN: 1573-7209
DOI
https://doi.org/10.1007/s10456-014-9439-0

Weitere Artikel der Ausgabe 4/2014

Angiogenesis 4/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.